Location History:
- Søborg, DK (2008 - 2019)
- Soborg, DK (2014 - 2019)
Company Filing History:
2 out of 8 
2 out of 9 
1 out of 12 Years Active: 2008-2019
Title: Carsten Martini Nielsen: Innovator in Pharmaceutical Materials
Introduction
Carsten Martini Nielsen is a notable inventor based in Soborg, Denmark. He has made significant contributions to the field of pharmaceutical materials, particularly in the development of particulate formulations. With a total of 5 patents to his name, Nielsen's work focuses on enhancing the efficacy and usability of solid dosage forms.
Latest Patents
One of Nielsen's latest patents involves a particulate material comprising a calcium-containing compound and a sugar alcohol. This invention relates to a solid dosage form, notably tablets, that includes a regularly shaped calcium-containing compound, such as a calcium salt, which serves as a therapeutically and/or prophylactically active substance. The formulation also incorporates a pharmaceutically acceptable sugar alcohol, such as sorbitol or isomalt, characterized by a microstructure as evidenced by scanning electron microscopy (SEM). The process for preparing this particulate material involves agglomeration through roller compaction, making it suitable for further processing into tablets, including chewing tablets.
Career Highlights
Throughout his career, Carsten Martini Nielsen has worked with prominent companies in the pharmaceutical industry, including Takeda Nycomed and Takeda. His experience in these organizations has allowed him to refine his expertise in the development of innovative pharmaceutical products.
Collaborations
Nielsen has collaborated with several professionals in his field, including Poul Bertelsen and Peder Mohr Olsen. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Carsten Martini Nielsen stands out as an influential inventor in the pharmaceutical sector, with a focus on innovative particulate formulations. His contributions continue to impact the development of effective solid dosage forms, showcasing his commitment to advancing pharmaceutical science.